Florida Cancer Specialists & Research Institute Welcomes Thanuja Neerukonda, MD and Jaskirat S. Sethi, MD PR Newswire
Imfinzi plus Imdelltra demonstrated a statistically significant and highly clinically meaningful improvement in overall survival and progression-free survival in 1st-line extensive-stage small cell lung cancer AstraZeneca
IMDELLTRA® IN COMBINATION WITH IMFINZI® DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER PR Newswire
The V Foundation for Cancer Research Awards $1.8 Million in Grants to Children's Hospital of Philadelphia Researchers PR Newswire
Project Optimus explained: what the FDA expects on oncology dosing The Pharma Letter
Победа над раком и распространение человекоподобных роботов: глава Arm рассказал о будущем ИИ Дзеркало тижня
Pushing the accelerator and the brake at the same time is rarely a good idea. But researchers at the University of Gothenburg are using this approach to treat leukemia. A new drug forces cancer cells to keep working hard even though they have run out of energy. The first study in mice shows very promising results.
BriaCell's Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center Investing News Network
Алкоголь - прямой путь в раку: кировский онколог развенчала мифы о «безопасных» дозах и пользе вина Вятка-на-Сети
Your Wednesday Wrap-Up - September 2 Targeted Oncology
Veru Inc. Announces Sabizabulin Overcomes Daraxonrasib Resistance in Preclinical Pancreatic Cancer Studies and Advances Phase 2b Development Plan Quiver Quantitative
Ovarian cancer has a particularly poor survival rate. Only one in two women will live five years beyond their diagnosis. There is no effective screening test, and symptoms can be hard to spot. This means ovarian cancer is often diagnosed when it is already well advanced.
Liver cancer patients appear to be living longer in a Can-Fite trial Stock Titan
Кубанская журналистка Симоньян 8 сентября узнает результаты борьбы с раком KrasnodarMedia
David Tuveson to join Duke Health as executive director of the Duke Cancer Institute Duke University School of Medicine